Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Phase III Randomized, Double-Blind, Active-Comparator Controlled Clinical Trial to Study the Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4, and 12 Months https://kusajili.com:443/Trial/J47SDf2Sl0Ku4FH6O69hoA%24a-phase-iii-randomized-double-blind-active-comparator-controlled-clinical-trial-to-study-the-safety-tolerability-and-immunogeni
I have read and accept the terms of use of the site and the Privacy Policy
Send your message